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Genomics, Stockholm, Sweden and 7) Department of Bacteriology and Immunology, University of Helsinki, FinlandAbstractIn mice, speciﬁc species composition of gut microbiota enhances susceptibility to Campylobacter jejuni but little is known about the speciﬁc
composition of the human gut microbiota in providing protection from infections caused by enteropathogens. Healthy adult individuals, who
travelled in groups from Sweden to destinations with an estimated high risk for acquisition of Campylobacter infection, were enrolled. Faecal
samples, collected before travelling and after returning home, were cultured for bacterial enteropathogens, and analysed for Campylobacter by
PCR and for the species composition of the microbiota by 16S amplicon massive parallel sequencing. The microbiota compositions were
compared between persons who became infected during their travel and those who did not. A total of 63 participants completed the
study; 14 became infected with Campylobacter, two with Salmonella and 47 remained negative for the enteropathogens tested. After
exclusion of samples taken after antimicrobial treatment, 49 individuals were included in the ﬁnal analyses. Intra-individual stability of the
microbiota was demonstrated for samples taken before travelling. The original diversity of the faecal microbiota was signiﬁcantly lower
among individuals who later became infected compared with those who remained uninfected. The relative abundances of bacteria
belonging to the family Lachnospiraceae, and more speciﬁcally its two genera Dorea and Coprococcus, were signiﬁcantly higher among those
who remained uninfected. The travel-related infection did not signiﬁcantly modify the faecal microbiota composition. Species composition
of human gut microbiota is important for colonization resistance to Campylobacter infection. Especially individuals with a lower diversity
are more susceptible to Campylobacter infection.
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This is an open access artiIntroductionIt is becoming more and more certain that the composition of
the gut microbiota not only plays an important role in many
normal functions of the human body, such as the development
of the intestinal immune system, but is also connected to a
growing number of diseases [1–3]. Little is known, however,
about the role of the species composition of the human in-
testinal microbiota in providing protection from enter-
opathogens. Although the disrupted indigenous gut microbiotaClin Microbiol Infect 2016; 22: 61.e1–61.e8
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known to be the central factors leading to the development of
Clostridium difﬁcile infection [4], only very recently some speciﬁc
bacterial compositions of the gut community have been con-
nected to this infection [5,6]. For Salmonella, murine studies
indicate that the composition of the gut microbiota is important
for colonization resistance [7]. Microbiota characteristics, such
as a low complexity in general or high relative abundance of
Escherichia coli [8], may lead to a higher susceptibility to Sal-
monella enterica. However, human studies are few.
In Europe, Campylobacter has been the most commonly re-
ported bacterial enteropathogen in humans and the most
commonly reported zoonotic agent since 2005; in 2013 the
number of reported conﬁrmed human Campylobacter cases in
the EU was >200 000, Campylobacter jejuni and Campylobacter
coli being the dominant pathogens [9]. The role of the human
microbiota composition for the susceptibility to Campylobacter
infection remains elusive. However, immunocompetent mice,
naturally resistant to Campylobacter, could be successfully
colonized with C. jejuni, resulting in inﬂammation, if their in-
testinal microbiota was ﬁrst humanized [10]. Furthermore, in
mice, elevated numbers of intestinal E. coli were shown to
reduce colonization resistance to C. jejuni [11]. For the ﬁrst
time in humans, we recently showed that the faecal microbiota
of highly exposed poultry abattoir workers who later became
infected with Campylobacter had a signiﬁcantly higher relative
abundance of certain bacterial genera (e.g. Bacteroides and
Escherichia) than the microbiota of those who remained
Campylobacter negative [12]. In that particular study, we could
also demonstrate that Campylobacter infection had long-term
effects on the species composition of the microbiota.
In the present study, we assessed the species composition of
the faecal microbiota in generally healthy adults before and after
their international travel to destinations with high prevalence of
enteropathogens. All the individuals were culture negative for
enteropathogens at the beginning of the study but, during their
travel, about a quarter developed bacterial enteritis. We
detected clear differences in the initial composition of the faecal
microbiota among those who later became infected compared
with those who did not.Materials and methodsParticipants and sample collection
In this prospective, observational study, eight different groups
of travellers with a total of 67 people were recruited (19 men
and 48 women). Exclusion criteria included an age <18 or >65
years, a diagnosis of inﬂammatory bowel disease and failure to
understand written Swedish. The participants were generallyClinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licehealthy people living in Sweden (aged 18–64 years; median age
24 years) who travelled from 1 week to 3 months (median 2
weeks) to a foreign destination with a reasonable risk of
acquiring a bacterial enteropathogen (Egypt, Tunisia, Curaçao,
Turkey, Ecuador, Bangladesh or Tanzania) (Table 1). Only
people travelling in groups (encompassing at least three in-
dividuals) were recruited, so that comparisons could possibly
be made within the groups.
Faecal samples from each participant were collected twice
before the trip (with a median of 10 days apart; the second
sample collected 0–5 days, median 2 days, before travelling)
and once after return to Sweden (range 0–25 days after arrival;
median 3 days). On each sampling occasion, one sample was
immediately sent for routine bacterial culture to the Clinical
Microbiology Laboratory at Uppsala University Hospital,
whereas the other sample taken in parallel was kept at –70°C
for subsequent DNA extraction. On each sampling occasion
the participants also ﬁlled in a short questionnaire and mailed it
to the researchers. The questionnaires included information on
previous medical conditions and intake of antibiotics. Those
who became culture positive for enteropathogens during the
study received an additional questionnaire including questions
on intestinal symptoms and possible antimicrobial therapy.
All, except four participants from four different groups,
delivered all three samples. Fourteen of these 63 individuals
became infected with C. jejuni (11 culture positive and 3 only
PCR positive) during their trip, two became positive for
S. enterica and 47 remained uninfected. Given the alteration of
the microbiota caused by antibiotics, faecal samples collected
within 3 months of any antibiotic usage were excluded from
further microbiota analyses. In the ﬁnal analyses, 49 individuals
were included.
Written informed consent was obtained from each partici-
pant. The regional board of the ethics committee at Uppsala
University approved the study.
Bacterial isolation
All the faecal samples before and after travelling were cultured
by routine diagnostic methods for Campylobacter, Salmonella,
Shigella and Yersinia. All samples collected before travelling were
culture negative for these bacterial agents.
DNA extraction
DNA was extracted from approximately 200 mg of faecal
samples. Bead-beating was used to disrupt bacterial cell walls
and was performed in tubes containing TE-buffer (pH 7.5) and
0.1-mm zirconia/silica beads (BioSpec products, Bartlesville,
OK, USA) for 3–4 min at 20 Hz on a TissueLyser Adapter Set
2X24 (Qiagen, Düsseldorf, Germany). The DNA was then
isolated and puriﬁed using an easyMAG NucliSENS extractorEuropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 61.e1–61.e8
nses/by-nc-nd/4.0/)
TABLE 1. Participants and their samples included in the study
Groups originally recruited
according to travel destination
(no of participants) (n [ 67)
Finding in faecal culture/PCR
after travelling for those who
delivered all samplesa (n [ 63)
Included in analysis 1b
(n [ 57)
Included in analysis 2c
(n [ 51)
Included in analysis 3d
(n [ 49)
Touristse
Egypt (n = 4) Salmonella (n = 1)
Uninfected (n = 3)
Uninfected (n = 3) Uninfected (n = 3) Uninfected (n = 3)
Tunisia (n = 3) Uninfected (n = 3) Uninfected (n = 2) Uninfected (n = 2) Uninfected (n = 2)
Curacao (n = 6) Uninfected (n = 5) Uninfected (n = 5) Uninfected (n = 5) Uninfected (n = 5)
Turkey (n = 3) Uninfected (n = 3) Uninfected (n = 3) Uninfected (n = 3) Uninfected (n = 3)
All tourists (n = 16) Salmonella (n = 1)
Uninfected (n = 14)
Uninfected (n = 13) Uninfected (n = 13) Uninfected (n = 13)
Volunteersf
Ecuador (n = 7) Campylobacter (n = 3)
Uninfected (n = 4)
Campylobacter (n = 3)
Uninfected (n = 4)
Campylobacter (n = 3)
Uninfected (n = 4)
Campylobacter (n = 3)
Uninfected (n = 4)
Bangladesh (n = 22) Campylobacter (n = 5)
Uninfected (n = 16)
Campylobacter (n = 5)
Uninfected (n = 15)
Campylobacter (n = 5)
Uninfected (n = 13)
Campylobacter (n = 4)
Uninfected (n = 13)
Ecuador (n = 17) Salmonella (n = 1)
Campylobacter (n = 6)
Uninfected (n = 9)
Salmonella (n = 1)
Campylobacter (n = 6)
Uninfected (n = 7)
Salmonella (n = 1)
Campylobacter (n = 6)
Uninfected (n = 5)
Salmonella (n = 1)
Campylobacter (n = 5)
Uninfected (n = 5)
Tanzania (n = 5) Uninfected (n = 4) Uninfected (n = 3) Uninfected (n = 1) Uninfected (n = 1)
All volunteers (n = 51) Salmonella (n = 1)
Campylobacter (n = 14)
Uninfected (33)
Salmonella (n = 1)
Campylobacter (n = 14)
Uninfected (n = 29)
Salmonella (n = 1)
Campylobacter (14)
Uninfected (n = 23)
Salmonella (n = 1)
Campylobacter (n = 12)
Uninfected (n = 23)
aAll samples taken before travelling were culture-negative for Campylobacter, Salmonella, Shigella and Yersinia but after travelling some individuals showed positive faecal culture or
positive Campylobacter PCR result.
bIntra-individual stability of microbiota composition was analysed in two consecutive faecal samples collected with a median of 10 days apart before travelling; six individuals were
excluded due to antimicrobial use within the 3 months before travelling.
cMicrobiota composition of faecal samples collected before travelling and analysed among travellers who became infected later and those who remained uninfected; six further
individuals were excluded due to antimicrobial use during/after travelling as negative culture/PCR results after the trip were regarded as unreliable.
dMicrobiota compositions were analysed in faecal samples collected after travelling and compared with those of samples taken before travelling among participants who became
infected later and those who remained uninfected; two Campylobacter positive individuals further excluded due to antimicrobial intake during/after travelling.
eParticipants who attended short (for 1–2 weeks) trips as tourists.
fParticipants who studied/worked while abroad (for 2–12 weeks).
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DNA was extracted from Campylobacter isolates according to
the protocol above except without the bead-beating step.
Subtyping of Campylobacter isolates and PCR analysis
of faecal samples
Campylobacter isolates originally cultured on modiﬁed charcoal
cefoperazone deoxycholate agar plates (Oxoid, Basingstoke,
UK) and identiﬁed by colony appearance, positive oxidase
testing and microscopy, were further characterized by PCR
analysis. Duplex-PCR using primers speciﬁc for C. jejuni (tar-
geting mapA gene) and for C. coli (targeting ceuE gene) were
used [13,14]. Cycling conditions for PCR were 10 min at 95°C,
40 cycles of 30 s at 95°C, 90 s at 59°C and 1 min at 72°C, with
a ﬁnal extension step of 10 min at 72°C. PCR products were
separated with gel electrophoresis on 1.5% agarose gel and
bands were visualized using GelRed (Biotium, Hayward, CA,
USA). Campylobacter jejuni (81-176) and C. coli (LMG6440) were
used as positive controls and omission of template as a negative
control. All isolates were shown to be C. jejuni.
DNA from all the samples collected after travelling was
analysed by PCR for the presence of C. jejuni and C. coli as
described above. Culture-negative samples of three participants
after travelling were shown to be positive for C. jejuni by PCR;
for these particular individuals both samples taken before
travelling were also analysed by PCR and shown to be negative.Clinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access arti16S rRNA analysis
Sequencing libraries were prepared by amplifying the V3–V4
region of the 16S rRNA gene using the 341f-805r primers,
described by Hugerth et al. [15]. After the initial ampliﬁcation, a
second PCR was performed to attach Illumina adapters as well
as barcodes that allow for multiplexing. Samples were
sequenced using the Illumina MiSeq platform producing 300 bp
reads. Primer sequences were trimmed away and the paired-
end reads produced by the sequencing instrument were
merged using SEQPREP version 1.1 (https://github.com/jstjohn/
SeqPrep) with default parameters and thereafter the merged
sequences were processed with the QIIME 1.8.0 pipeline
(Quantitative Insights Into Microbial Ecology) [16]. A closed
reference operational taxonomic unit (OTU) strategy was used
to assign sequences to OTUs. Using the UCLUST [17] algo-
rithm built into the QIIME pipeline, sequences were clustered
at 97% identity against the Greengenes reference database [18],
which produced 5917 OTUs in the data set with an average of
20 222 reads per sample (range 11 422–24 869). Details on 16S
rRNA gene primers, ampliﬁcation conditions and sample
barcodes were as published earlier [19].
Statistical analysis
Microbial diversity was calculated using Shannon’s index of di-
versity and phylogenetic diversity whole tree. QIIME was used
to generate weighted UniFrac distances to monitor changes in βEuropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 61.e1–61.e8
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
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PAST was used for graphical illustrations of data and for sig-
niﬁcance testing between groups; Wilcoxon rank-sum test
when two groups were compared and Kruskal–Wallis test
when three groups were compared [20].ResultsStability of the composition of faecal microbiota before
travelling
The intra-individual stability of the microbiota composition in
the two consecutive faecal samples collected before travelling
at a median interval of 10 days was analysed. As samples taken
within 3 months of any antimicrobial intake were excluded,
paired samples of 57 individuals were included (Table 1). The
samples were assessed by weighted UniFrac distance analysis
(Fig. 1), and the analyses were also performed separately for the
13 tourists (attending a 1– to 2-week-long trip as tourists) and
44 volunteers (who studied/worked for 2–12 weeks abroad),
respectively. There were no signiﬁcant differences between the
results of the tourists and the volunteers, and as the UniFrac
distance for intra-individual samples did not signiﬁcantly differ,FIG. 1. Intra-individual stability of microbiota composition in two
consecutive faecal samples collected before travelling. The intra-
individual stability was assessed by weighted UniFrac distance analysis
for all participants and separately for volunteers and tourists. No sig-
niﬁcant differences between the groups of volunteers and tourists were
detected. The horizontal line in the box plot represents the median
value and the box is drawn from 25% to 75% quartiles. Whiskers show
minimum and maximum values and circles represent outliers.
Clinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licethe second samples taken immediately before travelling were
regarded as representative and used in the further analyses.
Enteropathogen ﬁndings after travelling
During this study, 16 of the original 63 participants (25%)
became infected with enteropathogens (Table 1) as shown by
culture for Salmonella (n = 2), by culture for Campylobacter
(n = 11) or by PCR only for Campylobacter (n = 3). A total of 47
participants remained culture and PCR negative. Of the
Campylobacter-positive individuals (aged 18–29 years; median
age 23 years), 11 were women and three were men.
Campylobacter culture positive samples were collected 1–13
days (median 3 days) after returning home, and the three
culture-negative but PCR-positive samples were collected 4, 5
and 12 days after returning to Sweden. Three of the 14
Campylobacter-positive individuals reported no intestinal
symptoms during travelling; all three had faecal samples that
were positive for Campylobacter both by culture and by PCR.
Composition of the original faecal microbiota and
susceptibility to enteropathogens
To see whether the composition of faecal microbiota before
travelling was different among those who later became infected
compared with those who remained uninfected, the samples
taken before travelling were compared between the infected
and the uninfected groups. For this analysis, samples of 15
infected participants (14 positive for C. jejuni and one for
S. enterica) and 36 uninfected individuals were analysed
(Table 1).
The original taxon diversity of the faecal microbiota before
travelling was signiﬁcantly lower among the group of partici-
pants who later became infected as compared to those who
remained uninfected (Wilcoxon’s test; Shannon diversity p
0.028 and phylogenetic diversity whole tree p 0.002). As
analysed separately for the three groups of participants
(infected, uninfected tourists and uninfected volunteers), the
group of tourists who remained uninfected had the highest
diversity; it was even signiﬁcantly higher than that of the
volunteers who remained uninfected (Fig. 2). These results
remained signiﬁcant even after exclusion of the sample of the
only Salmonella-positive individual. The original composition
of faecal microbiota among the three individuals, who became
Campylobacter positive but remained asymptomatic during and
after travelling, was not different from the microbiota of
those who became Campylobacter positive and developed
symptoms.
We also wanted to study speciﬁcally whether relative
abundances of certain bacterial taxa differed between the
participants who later became infected and those who
remained uninfected. As infected individuals (after exclusion ofEuropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 61.e1–61.e8
nses/by-nc-nd/4.0/)
FIG. 2. Original taxon diversity of faecal microbiota before travelling. Taxon diversity was analysed separately for the participants who became
infected with Campylobacter/Salmonella (red), the tourists who remained non-infected (grey) and the volunteers who remained non-infected (brown).
Results are shown for Shannon’s index of diversity and phylogenetic diversity whole tree. The participants who became infected had signiﬁcantly lower
diversity compared with those who remained non-infected (Wilcoxon’s test). The horizontal line in the box plot represents the median value and the
box is drawn from 25% to 75% quartiles. Whiskers show minimum and maximum values and circles represent outliers.
CMI Kampmann et al. Faecal microbiota and Campylobacter infection 61.e5those treated with antimicrobials) could only be found among
the volunteers (Table 1), these comparisons were performed
between infected and uninfected volunteers only. Among the
23 participants who remained uninfected, higher relative
abundances of bacteria belonging to the family Lachnospiraceae
were detected (p 0,036, Fig. 3). Higher relative abundances
were also demonstrated separately for two genera, Dorea (p
0.004) and Coprococcus (p 0.002), both belonging to Lachno-
spiraceae. These results remained signiﬁcant even after
exclusion of the sample of the only Salmonella-positive
individual.
Inﬂuence of infection on the composition of faecal
microbiota
To see if the faecal microbiota was changed in response to the
imported infection, the samples collected after travelling were
compared with those taken before the trip and the analyses
were performed separately for the groups of infected and of
uninfected individuals. As eight people had taken antibiotics
during or after the trip and so were excluded from this analysis,
12 Campylobacter positive, 1 Salmonella positive and 36 unin-
fected participants were included (Table 1). These analyses
were also performed separately for the volunteers only (12
Campylobacter positive, 1 Salmonella positive and 23 uninfected
included). No signiﬁcant changes in the composition of faecal
microbiota were detected because of the imported infection
(data not shown). Sequences classiﬁed as Campylobacter spp.
were only found in very low relative abundances (0.004–0.4%)
and in the samples of eight Campylobacter-positive (culture/
PCR) individuals.Clinical Microbiology and Infection © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access artiDiscussionCampylobacter jejuni is a leading cause of bacterial enteritis in the
world but little is known about the pathogenic mechanisms
involved [21]. We wanted to study the role of the human gut
microbiota in the development of Campylobacter infection and
prospectively followed Swedish travellers with analyses of their
faecal microbiota compositions before and after travelling
abroad. Signiﬁcant differences were detected in the faecal
microbiota compositions between individuals who became
infected with Campylobacter and those who remained
uninfected.
The general concept of colonization resistance, i.e. the
microbiota’s capability to prevent and limit pathogen coloni-
zation and growth, has been well established for a long time, as
the use of antibiotics was shown to immediately increase sus-
ceptibility to Salmonella infection in mice [22,23]. However,
with the recent advances in sequencing technology, including
high-throughput DNA sequencing and bioinformatics, it has
now become possible to deﬁne the impact of speciﬁc bacterial
genera [24]. Studies using mouse models for colonization
resistance against C. jejuni indicate gut microbiota composition
to have an important role and imply that similar aspects would
be important for human C. jejuni infections as well [10,11] but
results from human studies performed with next-generation
sequencing techniques are very few [12,25].
The results of the present study are in line with those of
Stecher et al. [8], who found that mice with microbiotas of high
diversity were more resistant to S. enterica colonization thanEuropean Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 61.e1–61.e8
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
FIG. 3. Relative abundances of taxa, which differed signiﬁcantly be-
tween volunteers who became Campylobacter/Salmonella positive (red)
and those who remained negative (brown) (Wilcoxon’s test). The
61.e6 Clinical Microbiology and Infection, Volume 22 Number 1, January 2016 CMI
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antimicrobial agents. However, in our earlier study, which was
also performed in humans, we could not ﬁnd any signiﬁcant
difference in the diversity of the faecal microbiota between
poultry abattoir workers who later became infected by
Campylobacter and those who remained uninfected [12]. This
discrepancy could be, at least to some extent, explained by the
differences in the study populations in general and the presence
of symptoms in particular. In our earlier study, all but one of the
Campylobacter-positive abattoir workers were asymptomatic
whereas in our present study 11 of the 14 Campylobacter-pos-
itive travellers reported intestinal symptoms of varying degree.
Higher relative abundance of bacteria belonging to the family
Lachnospiraceae was demonstrated among the participants who
remained uninfected. This is in line with our earlier study
showing the same ﬁnding for unclassiﬁed Lachnospiraceae
among poultry abattoir workers who remained Campylobacter
negative [12]. In the present study, also higher relative abun-
dances of two genera, Dorea and Coprococcus, belonging to the
Lachnospiraceae family were shown for those who remained
uninfected. However, signiﬁcantly higher relative abundances of
Bacteroides and Escherichia, earlier shown to be associated with
a higher susceptibility for enteropathogens as demonstrated by
us in the abattoir study [12] and by others in animal models
[8,10,11], could not be veriﬁed in the present study. These
ﬁndings, and actually the lack of them in the present study,
highlight the complexity of faecal microbial communities.
Human gut microbiota in healthy adults is generally consid-
ered to be stable over time [26,27] but antimicrobial therapy
rapidly causes signiﬁcant changes in the taxonomic composition
of gut microbiota [28,29]. In our study, all samples taken within
3 months of any antimicrobial use were excluded. Intra-
individual stability was studied for the consecutive samples
taken before travelling and no signiﬁcant differences were
detected.
Our aim was also to see how the original faecal microbiota
was modiﬁed by the enteric infection obtained. In our study on
poultry abattoir workers [12], Campylobacter infection was
shown to cause long-term alterations to faecal microbiota
compositions of the infected individuals whereas among partic-
ipants who remained Campylobacter negative, microbiota com-
positions were stable even in samples taken more than 5 months
apart. In a recent study [25], it was shown that the relative
abundances of Enterobacteriaceae increased dramatically in the
faecal microbiota of an individual with Salmonella infection andhorizontal line in the box plot represents the median value and the box
is drawn from 25% to 75% quartiles. Whiskers show minimum and
maximum values and circles represent outliers.
European Society of Clinical Microbiology and Infectious Diseases, CMI, 22, 61.e1–61.e8
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Salmonella infection in the particular individual. However, in the
present study, faecal microbiota compositions of individuals who
developed Campylobacter infection did not show signiﬁcant
changes when the samples taken before travelling and those
collected after return to Sweden were compared.
Human studies on colonization resistance against enter-
opathogens have been hampered by the lack of prospective
samples collected before the infection. The strength of the
present study is that enteropathogen-negative faecal samples
taken before travelling were available for microbiota compo-
sition analyses.
There were only a few dropouts as 63 of the 67 individuals
originally recruited to the study gave all three faecal samples.
The infection rate was high among the participants but unevenly
distributed between the two groups because all except one of
the included infected individuals were actually detected among
the volunteers. The clearly higher incidence of bacterial en-
teritis among the volunteers could have been due to a generally
higher risk for Campylobacter infection in the particular desti-
nations, usually longer travelling time (median 80 days), or
possibly more primitive living conditions abroad compared with
those of the tourist trips. It can only be speculated if the par-
ticipants attending the tourist trips in this study were less
susceptible for enteropathogens due to their intestinal micro-
biota composition (as showing signiﬁcantly higher diversity of
their original faecal microbiota compared with the volunteers
who remained uninfected) or if they actually would have
become infected when attending the volunteer journeys.
Although the exact mechanisms underlying human coloni-
zation resistance against C. jejuni presumably are multi-factorial
and so far poorly understood, our current results give further
insights into the interplay between C. jejuni and human gut
microbiota. Our data might help to identify those individuals at
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